Oncodetect On-Demand Recording

Oncodetect On-demand Recording

Watch our Industry Expert Theater session from the 2025 ASCO^® Annual Meeting: Molecular Residual Disease Testing with Exact Sciences’ Oncodetect™ test: Product and Clinical Data Overview, presented by our Chief Medical Officer Rick Baehner, MD, and Director of Medical Development Somasundaram Subramaniam, MD, MS.

View this recording to:

Get introduced to the Oncodetect MRD test
Understand how the test detects MRD in solid tumors
Explore clinical validation results in colorectal cancer

Molecular Residual Disease testing with Exact Sciences Oncodetect test product and clinical data overview.

View the recording now

Please complete the form below. All fields are required, unless noted as optional.

Footnotes

This test was developed, and its performance characteristics determined by Genomic Health, Inc. The Oncodetect test was clinically validated in colorectal cancer patients with stage II-IV disease. Performance characteristics may not apply in tumor types not included in this test’s clinical validation. The test has not been cleared or approved by the US Food and Drug Administration. The test has been validated as a Laboratory Developed Test per institutional and applicable CLIA regulation (CLIA# 03D2048606) and College of American Pathology (CAP# 8869063) as qualified to perform high complexity clinical laboratory testing.

Not an official event of the 2025 ASCO^® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO^®, Association for Clinical Oncology, or Conquer Cancer^®, the ASCO Foundation. Not CME-accredited.

View our latest presentation

View the recording now

Footnotes